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Abstract
Children with Neurofibromatosis type 1 (NF1) are increasingly recognized to have high 
prevalence of social difficulties and autism spectrum disorders (ASD). We demonstrated selective 
social learning deficit in mice with deletion of a single Nf1 gene (Nf1+/−), along with greater 
activation of mitogen activated protein kinase pathway in neurons from amygdala and frontal 
cortex, structures relevant to social behaviors. The Nf1+/− mice showed aberrant amygdala 
glutamate/GABA neurotransmission; deficits in long-term potentiation; and specific disruptions in 
expression of two proteins associated with glutamate and GABA neurotransmission: a disintegrin 
and metalloprotease domain 22 (ADAM22) and heat shock protein 70 (HSP70), respectively. All 
of these amygdala disruptions were normalized by co-deletion of p21 protein-activated kinase 
(Pak1) gene. We also rescued the social behavior deficits in Nf1+/− mice with pharmacological 
blockade of Pak1 directly in the amygdala. These findings provide novel insights and therapeutic 
targets for NF1 and ASD patients.
Introduction
Affecting roughly 1 in 3000 children, NF1 is one of the most common single gene disorders, 
resulting in the development of complex tumors known as neurofibromas with significant 
cognitive and learning disabilities1,2. A number of studies demonstrate deficits in social 
information processing and social behaviors in over 50% of NF1 patients3–6, with 20–30% 
reaching the severity of clinical diagnosis of autism spectrum disorders (ASD)7–9. Further 
analyses of these social deficits in NF1 patients suggest that there are problems in facial 
emotional recognition (especially fear), a task that is specifically linked to human amygdala 
function6,10.
Thus, NF1 mutation presents an important single gene disruption model that could provide 
insights into the molecular mechanisms for social learning deficits and pathophysiology of 
ASD. Social learning is the product of complex interactions between multiple structures in 
the CNS, particularly the amygdala, striatum, hippocampus, fusiform area and frontal 
cortex11–13. Using homologous recombination to disrupt the murine homologue of NF1 
(Nf1), loss of a single Nf1 allele in mice (Nf1+/− mice) reduces neurofibromin levels in 
multiple organs, and recapitulating the phenotypes of the human condition14. Specifically, it 
causes deficits in some forms of spatial learning, as well as disrupted hippocampal long-
term potentiation (LTP)15,16. In addition to the hippocampus, Nf1+/− mice also show 
significant reductions in neurofibromin levels in the amygdala and frontal cortex, CNS sites 
critical for social behaviors and emotional regulation. Therefore, the present study was 
conducted to test if Nf1+/− mice demonstrate disruptions in social behaviors and to elucidate 
cellular or molecular changes in CNS sites associated with social behaviors.
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Results
To determine whether Nf1+/− mice demonstrate disrupted social learning, we used a well 
validated three chamber social memory test17. On initial exposure to the testing apparatus, 
both WT and Nf1+/− strains spent significantly more time interacting with an unfamiliar 
mouse over an inanimate object [n=12/12; side preference effect F1,22 = 105.8, p < 0.001, 
but no Nf1+/− interaction, F1,22 = 0.9, p = 0.358, Fig. 1a], demonstrating that the Nf1+/− 
genotype does not affect conspecific social cue recognition in mice (labeled baseline social 
behavior). After a 10 min interval, mice were retested with a choice between a novel mouse 
and the previous familiar mouse to assess their short-term social memory18. Both WT and 
Nf1+/− genotypes spent significantly more time with the new mouse [n=12/12, side 
preference effect F1,22 = 105.8, p < 0.001, but no Nf1+/− interaction, F1,22 = 0.4, p = 0.554; 
Fig. 1b], suggesting that Nf1+/− mice show normal ability to discriminate and immediately 
recall social cues. However, when presented with yet another novel mouse and the 
previously “familiar” mouse 24 hours later, the Nf1+/− mice did not show increased 
exploration of the novel mouse compared to the “familiar” mouse, whereas the WT mice 
showed robust preference for the novel mouse [n=12/11, side preference effect F1,21 = 9.9, 
p = 0.005, and a Nf1+/− interaction, F1,21 = 5.3, p = 0.032; Fig. 1c–d]. These results 
indicate that Nf1+/− mice, while showing normal immediate social discrimination at 
baseline, were unable to retain or recall the social memory and discriminate between 
familiar and unfamiliar social cues following a 24-hour delay.
To confirm if this deficit was selective for social learning or generalized to other amygdala-
cortical circuits, we also tested the performance of Nf1+/− mice in other novelty and 
emotional learning paradigms. We confirmed that compared to WT, Nf1+/− mice did not 
demonstrate deficits in learning in a novel object recognition test [n=5/5, object preference 
effect F1,8 = 8.9, p = 0.017, but no Nf1+/−interaction, Fig. 1e], or avoidance learning in 
passive avoidance test [n=9,6, avoidance effect F1,13 = 16.1, p = 0.001, but no Nf1+/− 
interaction, Fig. 1f]. Ability to demonstrate innate avoidance of a fear stimulus 24 hours 
later was also tested by utilizing the elevated plus-maze as previously described19. When 
tested 24 hours later, both genotypes showed similar increases in the avoidance of the open 
arms, suggesting normal retention of memory for aversive cues and avoidance in both 
genotypes [n=12/12, respectively, a day effect for duration F1,22 = 10.1, p = 0.003, Fig. 1g, 
and entries F1,22 = 11.5, p = 0.003, Fig. 1h in open arms but no Nf1+/− interactions]. 
Similarly, utilizing the Porsolt forced swim test, we measured the development of behavioral 
despair 24 hours later in the Nf1+/− mice. The WT and Nf1+/− mice both showed normal 
learning in the forced swim test [n=12/12, day effect F1,22 = 5.1, p = 0.034, but no Nf1+/− 
interaction, Fig. 1i]. The Nf1+/− mice were also tested for differences in the ability to 
discriminate olfactory cues, another possible confound that could result in mice showing 
poor social learning. In a standardized olfactory habituation test both WT and Nf1+/− mice 
demonstrated similar learning [n=6/6, Water, test effect F2,20 = 15.2, p < 0.001, Almond, 
test effect F2,20 = 7.4, p = 0.004, and, novel mouse, test effect F2,20 = 37.1, p < 0.001, but 
no Nf1+/− interactions, Fig. 1j]. Thus, Nf1+/− mice appeared to have selective and 
circumscribed deficits in long-term retention of social information.
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The NF1 gene encodes neurofibromin, which negatively regulates Ras GTPase activation 
(see Suppl. Fig. 1a for hypothetical illustration). Mutation at the Nf1 locus increases the 
output of MAPK and PI3K signal transduction from the cellular membrane to the nucleus 
resulting in the hyperactivation of the products of its downstream pathways such as 
phosphorylated ERK20,21. Therefore, we first tested whether neurons cultured from Nf1+/− 
mice would display a similar hyperactivation of MAPK following growth factor stimulation. 
Application of recombinant murine Stem Cell Factor (SCF; 10 ng/ml) increased the 
pERK1/2 levels to significantly greater degree in frontal cortical neurons cultured from 
Nf1+/− mice when compared to those cultured from WT mice (n=3/3, pERK/total ERK post 
stimulation, t4 = −4.0, p = 0.017, Fig. 1k). Applying SCF to amygdala cultures Nf1+/− mice 
increased pERK1/2 by ~100% compared to a ~ 50% increase in WT mice (n=4/4, pERK/
tERK post stimulation, t6 = −1.8, p = 0.114, Fig. 1k). To complement these in vitro 
findings, we also assessed pERK immunostaining in subregions of the amygdala in WT and 
Nf1+/− mice following exposure to a novel mouse. Compared to WT mice, Nf1+/− mice had 
increased numbers of pERK immunoreactive cells in the basolateral amygdala [BLA: t9 = 
3.2, p = 0.010], but not medial amygdala (n=5/6, t9 = 1.2, p = 0.262, Fig. 1l), further 
demonstrating hyperactivity of MAPK pathways in neurons responding to a social cue.
PAK1 is a downstream effector regulated by the Rho family of GTPases and positively 
regulates MAPK activation, and deletion of Pak1 gene (Pak1−/− mice) could potentially 
normalize the hyperactivation of MAPK pathways seen in the Nf1+/− mice as previously 
demonstrated in macrophages22 (see Suppl. Fig. 1a). In order to confirm that this approach 
could normalize social learning deficits in Nf1+/− mice, we tested if genetic intercross 
(Nf1+/−/Pak1−/−) would restore the learning deficits seen in Nf1+/− mice. We found that 
Nf1+/−, Nf1+/−/Pak1−/−, and Pak1−/− strains showed no differences in baseline social 
preference (n=12/11/6, side preference effect F1,26 = 100.5, p < 0.001, but no genotype 
interaction, Fig. 2a) or short-term social learning (n=12/11/6, side preference effect F1,26 = 
32.7, p < 0.001, but no genotype interaction, Fig. 2b]. As before, deficits were seen in 
Nf1+/− mice in long-term social learning, but importantly, co-deletion of Pak1−/− in Nf1+/− 
mice (Nf1+/−/Pak1−/− mice) clearly restored this learning deficit [n=12/11/6, side preference 
effect F1,26 = 7.5, p = 0.011, and a genotype x side preference interaction that approached 
significance F1,26 = 3.3, p = 0.054, a Fisher’s exact test determined that Nf1+/−/Pak1−/− 
mice show a greater novel mouse preference (= 10 sec criteria) than Nf1+/− mice p = 0.036, 
Fig. 2c–d]. Similar to our previous results with Nf1+/− mice, we detected no differences in 
anxiety (n=12/11/6, day effect F2,26 = 36.6, p < 0.001, but no genotype interaction, Fig. 2e), 
or olfaction (n=12/11/6, test 1–3 effects were noted for water, F2,30 = 12.2, p < 0.001, 
almond, F2,30 = 23.2, p < 0.001, novel mouse, F2,30 = 26.3, p < 0.001, but not genotype 
interactions; Fig. 2g) between the Nf1+/− and Nf1+/−/Pak1−/− mice. Although despair-
associated behaviors are not different between WT and Nf1+/− mice (Fig. 1i), compared to 
Nf1+/− mice the Nf1+/−/Pak1−/−, and Pak1−/− mice had reduced despair associated 
immobility (n=12/11/6, genotype effect, F2,26 = 6.9, p = 0.004; day effect F2,26 = 9.2, p = 
0.005; but no genotype interaction, Fig. 2f). Overall, these results determined that 
constitutive Pak1 co-deletion could rescue the social learning deficits in Nf1+/− mice.
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Since the amygdala is important in social learning11–13 and we observed hyperactivity of 
MAPK pathways in BLA neurons of Nf1+/− mice post novel mouse exposure (Fig. 1l), we 
next assessed functional changes in the amygdala networks in WT, Nf1+/−, Nf1+/−/Pak1−/− 
and Pak1−/− mice. Using whole-cell patch-clamp from BLA principal neurons we studied 
spontaneous excitatory and inhibitory postsynaptic currents (sEPSCs and sIPSCs, 
respectively). While pyramidal neurons of the BLA from Nf1+/− mice exhibited no 
differences in the amplitudes of either sIPSC [n=4/4/3/3 mice/genotype and n=11/11/14/14 
cells patched/genotype, no Nf1+/− x Pak1−/− interaction, F1,46 = 0.1, p = 0.77, Fig. 3a,b] or 
miniature IPSCs (mIPSCs) [no Nf1+/− x Pak1−/− interaction, F1,46 = 0.3, p = 0.59, Fig. 
3a,b], they did show significant increases in the frequencies of both sIPSC [Nf1+/− x 
Pak1−/− interaction, F1,46 = 6.11, p = 0.017, Fig. 3a,c] and mIPSC [Nf1+/− x Pak1−/− 
interaction, F1,46 = 9.21, p = 0.004, Fig. 3a,c] compared to WT mice. Furthermore, co-
deletion of Pak1 completely normalized the increase in frequency, without affecting the 
amplitude of sIPSC and mIPSC in the amygdala neurons [Fig. 3a–c], confirming that Pak1 
deletion also restores the increased BLA network inhibitory activity induced by Nf1 
mutation.
Next, analysis of both sEPSCs and mEPSCs from pyramidal neurons in the BLA of Nf1+/− 
mice showed significant increases in frequency of sEPSCs [Nf1+/− x Pak1−/− interaction, 
F1,62 = 4.53, p = 0.037] and mEPSCs [Nf1+/− x Pak1−/− interaction, F1,56 = 3.99, p = 
0.05,], but not amplitude of sEPSCs [no Nf1+/− x Pak1−/− interaction, F1,62 = 2.68, p = 
0.107] and mEPSCs [n=4/4/3/3 mice/genotype and n=11/11/14/14 cells patched/genotype, 
no Nf1+/− x Pak1−/− interaction, F1,56 = 1.03, p = 0.314, Fig. 3d–f]. We detected additional 
significant increases of the amplitude of sEPSCs [Pak1−/− effect, F1,62 = 76.63, p < 0.0001] 
and mEPSCs [Pak1−/− effect, F1,56 = 148.7, p < 0.0001] in Pak1−/− and Nf1+/−/Pak1−/− 
mice. These network changes suggest increases in presynaptic GABA release in the BLA of 
Nf1+/− mice, consistent with those reported in the hippocampus16. However, unlike the 
hippocampus, there appeared to be additional changes in glutamate neurotransmission in the 
amygdala of Nf1+/− mice.
To determine whether changes in synaptic plasticity within the amygdala might account for 
the social learning impairments of Nf1+/− mutants, we examined long-term potentiation 
(LTP) in BLA slices from these mice. Using a theta-burst stimulation (TBS) protocol23, we 
elicited persistent potentiation of excitatory postsynaptic potentials (EPSPs) in WT mice that 
lasted at least beyond 60 min after stimulation. In the Nf1+/− mice, while initial potentiation 
was comparable to WT neurons, we observed significant decay over the time [n=6/6/4/4 
mice/genotype and an n=7/12/8/5 cells patched/genotype; Fig. 3g–i]. By 50 min after the 
stimulation, the amplitude of EPSPs was no longer significantly different from those 
recorded 5 min prior to TBS in Nf1+/− mice [Nf1+/− effect over time F14,392 = 0.6, p = 
0.838]. In contrast, LTP induced in Nf1+/−/Pak1−/− mice was equivalent to that of the WT 
mice [genotype by time interaction F42,392 = 3.2, p < 0.001, Fig. 3g–i]. Finally, the 
amplitude of EPSPs, induced by TBS in Pak1−/− mice was comparable with amplitude of 
EPSPs recorded from BLA neurons of WT mice [Pak1−/− effect over time, F14,392 = 2.8, p < 
0.001, Fig. 3g–i]. These results determined that Nf1+/− mice had disrupted amygdala LTP 
and Pak1 deletion can rescue these LTP deficits.
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We next utilized mass spectrometry to measure expression levels of synaptic and neuronal 
proteins in the amygdala of WT, Nf1+/−, Nf1+/−/Pak1−/− and Pak1−/− mice. Our plan was to 
first identify proteins that were changed in Nf1+/− mice, compared to WT, and then 
determine which of those altered proteins were specifically restored in Nf1+/−/Pak1−/− mice 
without being similarly altered by deletion of Pak1 gene alone. The group of proteins thus 
identified would likely be the key to the disruption of the amygdala network observed in the 
Nf1+/− mice. Based on our selection algorithm, out of the 380 proteins measured, we 
identified only three proteins in the BLA that met all three selection criteria, i.e., they were 
disrupted in Nf1+/− mice compared to WT (criteria one, 73 proteins, see Suppl. Table 1); 
were not changed in Pak1−/− mice compared to WT (criteria 2); and were rescued to near 
WT levels in Nf1+/−/Pak1−/− mice (n=6/6/6/6, Table 1). There was dramatic >6 fold 
reductions in the levels of ADAM22 [Nf1+/− effect F1,24 = 22.1, p < 0.001, Fig 4a], and 
more modest increases in Cyclase Associated Protein (Cap1) [Nf1+/− x Pak1−/− interaction, 
F1,23 = 7.4, p = 0.013, Fig. 4a], and HSP70 [Nf1+/− x Pak1−/− interaction F1,24 = 7.3, p = 
0.014, Fig. 4b] in the Nf1+/− mice, and all were rescued by Pak1 co-deletion. Utilizing 
immunocytochemistry, we further confirmed that there was a significant reduction only in 
the number of ADAM22 positive cells (n=5/7/6/6, Nf1+/− effect F1,24 = 7.1, p = 0.015, 
Pak1−/− effect F1,24 = 6.7, p = 0.018 Fig. 4c,f], while the numbers of CAP1 and HSP70 t9 
= −1.0, p = 0.337 and HSP70 t9 = −0.3, p = 0.748 positive cells were unaltered [n=4/6 (one 
outlier removed from WT group), and n=4/7 respectively, Fig. 4d–e] in the BLA of Nf1+/− 
mice compared to WT. This reduction in ADAM22 positive cells was also rescued in the 
Nf1+/−/Pak1−/− mice.
Utilizing constitutive gene deletion, one cannot definitively conclude that the social learning 
deficits are being rescued by selective Pak1 inhibition within the amygdala. Therefore, in a 
subsequent experiment we tested the effects of bilaterally injecting previously known 
effective doses of a Pak1 inhibitor [IPA3, or its inactive enantiomer PIR3.5 (PIR3.5) as 
control] into the BLA of Nf1+/− mice 30 min prior to assessment in the social familiarity test 
on day 1 and 2. Pre-injecting of IPA3 (100μM/100nl), and not PIR3.5, into the BLA 
increased preference for the novel mouse in Nf1+/− mice during the long-term social 
memory test. Interestingly, IPA3 injection into the BLA also increased social preference in 
WT mice during the long-term social memory test even above their baseline further 
supporting the role of the BLA and Pak1 activity in social learning (n=6/6/6/6, side 
preference x Nf1+/− interaction, F1,18 = 5.2, p = 0.036, and side preference x Pak1 inhibitor 
interaction, F1,18 = 8.8, p = 0.008 Fig. 5a–c). Additionally, we also confirmed that there 
were reduced numbers of ADAM22 immunoreactive cells in the BLA of Nf1+/− mice that 
was rescued in Nf1+/− mice pre-treated with the IPA3 into the BLA (n=3/3/3/3, Nf1+/− 
effect, F1,12 = 9.7, p = 0.014, and Pak1 inhibitor effect, F1,12 = 10.0, p = 0.013, Fig. 5d–e). 
To validate that the doses of IPA3 (and not the inactive enantiomer PIR3.5) blocks Pak1 
function in the amygdala, we tested the effects of pre-injecting these drugs (100μM/100nl) 
on the increases in the number of pERK-ir cells following stimulation with DMSO, a known 
activator of Pak1 activity in neurons24,25. Injections of DMSO induced increases in pERK 
expression in the amygdala, whereas pre-injection with IPA3, but not PIR3.5 was able to 
block these effects (n=5/3/4, Suppl. Fig. 2a,d,e, F2,11 = 22.6, p < 0.001). Acute activation of 
Pak1 with injections of DMSO into the BLA of WT mice also caused a reduction in the 
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number of ADAM22-ir cells and IPA3 (and not PIR3.5) pre-injections blocked those 
reductions as well (n=5/3/4, F2,11 = 6.2, p = 0.020; Suppl. Fig. 2b,d,e).
Discussion
In summary, our findings demonstrated that Nf1+/− mice exhibit a selective deficit in social 
learning and the mechanisms underlying these social learning deficits appear to be 
disruption in the regulation of classical MAPK pathway in the amygdala. We have also 
determined that Nf1+/− mice show disruptions of synaptic plasticity (LTP), GABA-mediated 
inhibition and glutamate excitation of neurons, and altered expression of important synaptic 
proteins ADAM22 and HSP70 within the amygdala. ADAM22 is a synaptic protein that is 
thought to be critical for regulating the strength of glutamate neurotransmission and LTP, 
and shown to specifically anchor AMPA receptors on the post-synaptic terminals in the 
hippocampus26–28. Therefore, although the role of ADAM22 in anchoring AMPA receptors 
specifically in the amygdala has not yet been directly demonstrated, significant decreases in 
ADAM22 in Nf1+/− mice in the amygdala could be predicted to cause similar failure to 
anchor AMPA receptors to the post-synaptic membrane and sustain LTP as demonstrated in 
Nf1+/−mice (see Suppl. Fig. 1b for hypothetical illustration), Similarly, HSP70 is thought to 
be critical for anchoring the GABA synthetic mechanisms to the presynaptic terminals29 and 
increases in the expression levels of HSP70 could lead to increases specifically in pre-
synaptic GABA release and increased frequency of sIPSCs as demonstrated in this study. 
These increases in GABA release may also compensate for some of the glutamate 
neurotransmission disequilibrium and could be a potential explanation for Nf1+/− mice not 
developing severe seizures that are seen in ADAM22−/− mice30. CAP1 is a protein that plays 
an important role in the regulation of actin polymerization and synaptic remodeling, 
processes that are critical for long-term memory31.
The social deficits and all of the aforementioned amygdala disruptions in Nf1+/− mice were 
rescued by co-deletion of Pak1 gene. Pharmacological blockade of Pak1 function directly 
within the amygdala also rescued the social deficits seen in Nf1+/− mice. These results 
suggest that Pak1 inhibition, consistent with the recently reported neurofibroma tumor 
reductions in these children32, may represent a therapeutic target of interest for the treatment 
of NF1-related social and learning symptoms that pose a significant burden to these 
children1,32. Co-deletion of Pak1 gene, which rescued the behavioral deficits seen in Nf1+/− 
mice, also restored the changes in the synaptic protein expressions, and as predicted by our 
hypotheses, rescued the network disruptions in the amygdala, and normalized amygdala 
LTP. The precise mechanisms involved in these gene expression changes induced by Nf1 
haplo-insufficiency and their rescue by Pak1 deletion are yet to be determined. However, 
there is supportive evidence that inhibiting Pak1 levels will reduce CAP1 levels in the 
CNS33, and the genes for Pak1, Erk1 and LGl-4 (the endogenous CNS ligand for ADAM22) 
are all located on murine chromosome 7. Moreover, it has been shown, that single injection 
of Pak1 inhibitor completely rescues seizures and behavioral abnormalities such as 
hyperactivity and repetitive movements in Fragile X mental retardation 1 (Fmr1−/−) mice34. 
Finally, due to the increases in co-occurrence of NF1 and ASD35,36, these findings may also 
have important implications for the molecular targets for the remediation of social deficits in 
some forms of ASD. Indeed, a recent deep brain stimulation report show that directly 
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stimulating the BLA region in a severely autistic child was effective in improving core 
symptoms of the ASD in the emotional, social, and even cognitive domains over a follow up 
of 24 months37. To conclude, we have demonstrated selective deficits in social learning and 
underlying disruptions in the amygdala network caused by a single (Nf1) gene mutation. We 
have also provided a potential novel therapeutic approach towards ameliorating these 
disabling behavioral symptoms seen in patients with NF1 and some forms of ASD.
Online Methods
Animals
Most experiments were conducted using adult male mice, except for cellular assay and 
western blotting experiment, which was done in mice 2–3 days postnatal and 
electrophysiology experiments were done in 2–3 month old mice. The mouse strains tested 
were bred on a C57BL/6J background and included: (1) WT, (2) Nf1+/−, (3) Nf1+/−/Pak1−/− 
and (4) Pak1−/− mice. The Nf1+/− mice were obtained from Tyler Jacks at the 
Massachusetts Institute of Technology (Cambridge, MA), and Pak1−/− mice were obtained 
from Jonathan Chernoff (Fox Chase Cancer Center). To generate the Nf1+/−/Pak1−/− mice, 
Pak1−/− mice were intercrossed with the Nf1+/− strain. All mice were singly housed, given 
food and water ad libitum and maintained on a 12 hour light-dark cycle (7:00 am/7:00 pm) 
at 72°F. Animal care procedures were conducted in accordance with the NIH Guidelines for 
the Care and Use of Laboratory Animals (NIH Publication no. 80-23) revised 1996. All 
procedures have been approved by the Indiana University School of Medicine Institutional 
Animal Care and Use Committee (protocol no. 10326).
Behavioral testing
Behavioral testing reported in Figure 1a–d, g–h, I, and j were done in the same cohort of 
mice which were tested in the social behavior test on day 1, elevated plus maze (Fig. 1g) on 
day 2, olfactory test on day 3, and behavioral despair on day 4. Behavioral testing reported 
in Figure 1e and f were in done in the same cohort of mice, which were tested in the novel 
object recognition test on day 1, and passive avoidance test on day 2. Behavioral testing 
reported in Figure 2b–e, f, g, and h were done in the same cohort of mice which were tested 
in the social behavior test on day 1, elevated plus maze (Fig. 1g) on day 2, olfactory test on 
day 3, and behavioral despair on day 4. Social behavior tests reported in Figure 4 were done 
in a separate cohort of mice in a crossover design with 5 days between cross over. All 
behavioral tests were videotaped and independently scored at a later time by two individuals 
who were unaware of the animals’ genotype. Following each test, the apparatus were 
cleaned with 90% ethanol and dried.
Social behavior tests
The social interaction test was conducted as previously described39,40. Four 10 minutes 
sessions were conducted including (1) Day 1: acclimation (two empty cylindrical cages); (2) 
Day 1: 5 min after acclimation, preference for social interaction [novel mouse (mouse 1) and 
an empty cage]; (3) Day 1: 5 min after initial exposure to the mouse 1, a short-term social 
learning was done with mouse 1 (the now familiar mouse) and mouse 2 (a novel mouse); 
and (4) long-term social learning 24 hrs later [familiar mouse (mouse 2) and a novel mouse 
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(mouse 3)]. Following the “short-term social learning” session, the “novel” mouse was 
removed from the apparatus, and the “test” mouse was allowed to interact with the 
“familiar” mouse for an additional 45 minutes. The “stimulus” mice used for the social 
behavior tests were age-matched, adult male C57BL/6J mice that had no previous contact 
with the “test” mice.
Novel Object Recognition Test
The novel object recognition test (NORT) was used to measure short-term memory 
retention. The apparatus consisted of an opaque plexiglass chamber of (50 × 50 × 50 cm 
height). Two objects presenting similar textures, colors and sizes (2 cylinder) were placed in 
opposite corners of the chamber. Between trials, the objects and the box are cleaned with 
70% ethanol. The habituation session consisted of placing a mouse in the chamber for 10 
min, and at the end of each session the mouse was returned to the homecage. Two hours 
later, the mouse was placed in the chamber with a similar cylinder in each corner, and the 
time exploring (nose within 1 inch from object) the two objects was assessed for 10 min. 30 
min later, the mouse was placed in the chamber with the now familiar cylinder and an 
unfamiliar cube in each corner. The time exploring (nose within 1 inch from object) the two 
dissimilar objects was assessed for 10 min.
Passive Avoidance Memory Test
This passive avoidance task is a one trial fear-motivated avoidance task in which the mouse 
learns to refrain from stepping from a lighted chamber through a door to an apparently safer 
enclosed dark chamber where the mouse previously received a shock. The training chambers 
consist of one compartment (20×40×30cm height) that is lighted by an overhead stimulus 
light (40W bulb) and the other compartment (20×20×30cm height), which is black and 
enclosed so as to remain dark. An automatic guillotine door separated the two 
compartments.
On habituation day the mouse is placed in a lighted compartment facing away from the dark 
compartment; allowed to explore for 30 sec; then the door to the dark chamber is raised. 
When the mouse enters the dark compartment, the guillotine door is closed. 5 min later the 
mouse removed and returned to the home cage. On the training day, the test is repeated, 
except that upon entering the dark chamber the door is closed and the mouse receives a 
footshock (0.5 mA, 2 sec duration) through a grid. 30 seconds after the footshock the mouse 
is returned to the homecage. On testing day, the test is repeated and the latency to enter the 
dark chamber with front 2 paws is determined.
Elevated plus maze
The elevated plus-maze (EPM) was conducted as previously described41 where mice were 
allowed to freely explore the entire apparatus for five minutes. This procedure was again 
performed 24 hours later as a measure of avoidance learning. An arm entry was defined as 
having all four paws into the arm of the EPM.
Molosh et al. Page 9
Nat Neurosci. Author manuscript; available in PMC 2015 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
The Porsolt forced swim test
The forced swim test was utilized to measure aspects of behavioral despair41,42. The forced 
swim apparatus consisted of a cylindrical chamber constructed of clear Plexiglas with a 
diameter of 8.5 inches and height of 10 inches. For each trial, the chamber was filled with 25 
± 1°C water. The “test” mouse was then gently placed into the cylinder for 15 min. Twenty-
four hours later the mice were re-exposed to the same conditions for an additional six 
minutes trial. Immobility was considered the cessation of limb movements except minor 
involuntary hind limb movements.
Olfactory habituation test
The mice were placed in a clean cage, and were assessed for time spent sniffing cotton 
tipped swabs suspended from the cage lid. The cotton swabs were dipped in (1) water, (2) 
almond extract (1:100 dilution) or (3) wiped in a zig-zag pattern across the bottom surface of 
a cage that contained an unfamiliar mouse (a singly housed male mouse (C57BL/6J). 
Sequences of three identical swabs were assayed for each odor as follows: water, water, 
water, almond, almond, almond, unfamiliar cage, unfamiliar cage, unfamiliar cage. Each 
swab was presented for 2 min for a total session lasting 18 min per mouse.
Isolation and culture of neuronal cells from murine strains
Neurons were obtained from the frontal cortical and amygdala regions mice 2–3 days 
postnatal that were aseptically dissected and cultured from each respective genotype (WT, 
Nf1+/−, Nf1+/−/Pak1−/−, Pak1−/−). Following dissection of each respective brain region, 
neuronal cells were isolated by dissociation both enzymatically and mechanically (via 
trituration through a flame-polished Pasteur pipette) in a Papain solution (12 units/ml; 
Worthington) as described previously41. For this experiment, the neuronal cultures were 
assigned to one of two experimental conditions: (i) at basal levels and (ii) following the 
application of recombinant murine stem cell factor (SCF; PreproTech) at 10 ng/ml. SCF was 
applied to the neuronal cultures for 2 min. The cells were then washed with ice-cold PBS 
and lysed in buffer, as described below.
Immunoblotting ERK/pERK in mouse cortical and amygdala neurons
Whole cell protein extracts were obtained from the frontal cortical and amygdala regions of 
mice 2–3 days postnatal and placed in lysis buffer (50mM Tris pH 7.4, 150mM NaCl, 2mM 
EDTA pH 8.0, 1% Triton X-100, 1mM PMSF, 1mM NaF, 1mM Na3VO4, 10% glycerol 
and protease inhibitors). The samples were sonicated and cellular debris was removed by 
centrifugation at 13,000g for 30 min at 4°C. Protein concentrations were determined using a 
BCA assay (Thermo Scientific). Equivalent amounts of protein was electrophoresed on 10% 
SDS-PAGE gels, transferred to PVDF membranes (GE Healthcare, Little Chalfont, UK), 
and detected by Western blotting using the ECL Plus system (Amersham Biosciences). 
Antibodies used were phospho-ERK1/2 Antibody (cat. no. 4370, Cell Signaling 
Technology), ERK1/2 antibody (cat. no. 4695, Cell Signaling Technology), and GAPDH 
(cat. no. MAB374, Millipore). Cell Signaling reports the following: the ERK1/2 monoclonal 
antibody p44/42 MAP Kinase (137F5) Rabbit mAb detects endogenous levels of total 
p44/42 MAP kinase (Erk1/Erk2) protein. The antibody does not cross-react with JNK/SAPK 
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or p38 MAP kinase; and the ERK1/2 anti-phospho ERK monoclonal antibody is produced 
by immunizing rabbits with a synthetic phosphopeptide corresponding to residues 
surrounding Thr202/Tyr204 of human p44 MAP kinase, and binds to endogenous levels of 
p44 and p42 MAP Kinase (Erk1 and Erk2) when dually phosphorylated at Thr202 and 
Tyr204 of Erk1 (Thr185 and Tyr187 of Erk2), and singly phosphorylated at Thr202. This 
antibody does not cross-react with the corresponding phosphorylated residues of either JNK/
SAPK or p38 MAP kinases. All mice were delivered to RK, whom was unaware of the 
animals’ genotype.
Immunostaining of pERK cells in amygdala of mice exposed to novel mouse
Wildtype and Nf1+/− mice were habituated to the social learning apparatus with two empty 
cages, and then 24 hrs later placed in social learning apparatus with a novel mouse in one 
cage. Mice were then placed in homecage for 80 min then anesthetized with Isoflurane and 
perfused transcardially with 250 ml 0.1M PBS, followed by 250 ml of 0.1M PB containing 
4% paraformaldehyde and 3% sucrose and processed for immunohistochemistry, and to 
yield 4 alternative sets of serial coronal sections (30 μm). A standard immunohistochemical 
procedure was then performed as described in detail previously43, utilizing a monoclonal 
rabbit anti-phospho-ERK1/2 antibody (1:200 dilution; cat. no. 4370, Cell Signaling).
Protein expression analysis
Tissue slices were homogenized in 50 mM ammonium bicarbonate, and whole cell protein 
extracts were obtained from brain slices in lysis buffer (30mM Tris, pH 7.4, 150mM NaCl, 
1% Triton X-100, 0.1% SDS, 1mM PMSF, 10mM EDTA, 1mM Na2CO3, 160mM NaF, 
complete protease inhibitor) with ProteoSpin total protein detergent clean up micro kit 
(Norgen, Canada). BCA Protein Assay Kit (Pierce, Rockford, IL) was utilized to determine 
protein concentrations of the lysates (Pierce, Rockford, IL). Protein samples were reduced 
through DTT and alkylation was achieved by adding IAA. The protein samples then 
subjected to tryptic digestion at 37°C overnight and quenched through the addition of neat 
formic acid. LC-MS/MS analyses of the tryptic digests were performed using a Dionex 3000 
Ultimate nano-LC system (Dionex, Sunnyvale, CA) interfaced to LTQ Orbitrap hybrid mass 
spectrometer (Thermo Scientific, San Jose, CA). Prior to separation, a 2-μl aliquot of trypsin 
digestion (1.5 μg protein equivalent) was loaded on PepMap300 C18 cartridge (5 μm, 300 Å, 
Dionex) and eluted through the analytical column (150 mm × 100 μm i.d, 200 Å pores) 
packed with C18 magic (Michrom Bioresources, Auburn, CA). Peptides originating from 
protein tryptic digests were separated using a reversed-phase gradient from 3–55% B, 99.9% 
acetonitrile with 0.1% formic at 500 nl/min flow rate and passed through an ADVANCE 
ionization source (Michrom Bioresources, Auburn, CA). Switching between MS scan and 
CID-MS, eluted LC products undergo an initial full-spectrum MS scan from m/z 300 to 
2000 in the Orbitrap at 15,000 mass resolutions. Subsequently CID-MS (at 35% normalized 
collision energy) was performed. The total cycle (6 scans) is continuously repeated for the 
entire LC-MS run under data-dependent conditions. Mascot version 2.1.3 was used for all 
search results against Swiss-Prot database for house mouse, and the quantitative analysis of 
proteins was carried out using ProteinQuant Suit developed at Indiana University. The 
combined master files were then incorporated with their corresponding mzXML files and 
were submitted to ProteinQuant as described previously44. Pathway analyses were then 
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conducted on proteins that showed significant differences between WT and Nf1+/−, and 
were restored in the Nf1+/−/Pak1−/− genotype utilizing INGENUITY systems software 
(Redwood City, CA). Protein expression data were further analyzed using one-way and two-
way analyses of variance. All mouse tissue was given to the proteomics core collaborators, 
whom were unaware of the animals’ genotype.
Electrophysiology
The electrophysiological recordings were performed in 2–3 month old mice as described 
previously45. Briefly, following decapitation, the brains were rapidly removed and placed in 
oxygenated artificial cerebrospinal fluid (ACSF) [130mM NaCl; 3.5mM KCl; 1.1mM 
KH2PO4; 1.3mM MgCl2; 2.5mM CaCl2; 30mM NaHCO3; 10mM glucose], and coronal 
slices (350 μM) were prepared containing the basolateral amygdala (BLA). After initial at 
least 30 min incubation at 30°C in oxygenated ACSF slices were transferred to a recording 
chamber mounted on the stage of a Nikon E600FN Eclipse (Nikon Instruments, Melville, 
NY) microscope and perfused with ACSF [2–3 ml per minute] heated to 30°C. Whole-cell 
patch-clamp recordings were obtained using standard techniques. Borosilicate glass 
electrodes (WPI, Sarasota, FL) (resistance 3–6 MΩ) were prepared with a potassium 
gluconate based recording solution [130mM K-Gluconate, 3mM KCl, 3mM MgCl2, 5mM 
phosphocreatine, 2mM K-ATP, 0.2mM NaGTP, 10mM HEPES] and were maintained at a 
holding potential of −60 mV. BLA pyramidal neurons were identified according to their 
characteristic size and shape46. At the start of each experiment, except LTP experiments, a 
series of current clamp protocols were performed to further validate the identity of BLA 
projection neurons. Drugs were added directly into the ACSF at the required concentration. 
The spontaneous inhibitory postsynaptic currents (sIPSCs) and miniature IPSCs (mIPSC) [in 
the presence of 1 μM tetrodotoxin (TTX)] were recorded at a holding potential of −55 mV in 
the presence of DNQX (20 μM), CPP (10 μM). The spontaneous excitatory postsynaptic 
currents (sEPSCs) and miniature EPSCs (mEPSCs) [in 1 μM TTX] were acquired at a 
holding potential of −60 mV in the presence of GABAA antagonist bicuculline 
methochloride (10 μM) and GABAB antagonist CGP52432 (1 μM). The spontaneous and 
miniature currents were captured continuously for 1 min and detected and analyzed 
afterwards using the MiniAnalysis (Synaptosoft, Decatur, GA).
Excitatory postsynaptic potentials (EPSPs) onto BLA projection neurons were evoked in 
current clamp as previously described47. The GABAB antagonist CGP52432 (1 μM) was 
added to ACSF and GABAA antagonist picrotoxin (50 μM) was included into the recording 
solution. The holding potential was adjusted to −70 mV, except during theta-burst 
stimulation (TBS) when the potential was adjusted to −55 mV to facilitate spike firing. A 10 
min baseline period was recorded in each experiment and recordings continued for at least 
60 min after LTP induction. The TBS consisted of 40 msec duration, 100 bursts delivered at 
5 Hz for 5 sec (100 pulses total). Evoked postsynaptic potentials were analyzed using the 
pClamp 10.3 (Molecular Devices, Sunnyvale, CA). All chemicals, except CPP and 
CGP52432 (Tocris Biosciences, Ellisville, MO), were purchased from Sigma-Aldrich (St. 
Louis, MO). All mice were brought to AIM, who was unaware of the animals’ genotype.
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Immunohistochemistry for (ADAM22, CAP1 and HSP70) in the Basolateral Amygdala
Mice were anesthetized with Halothane then perfused transcardially with 250 ml 0.1M PBS, 
followed by 250 ml of 0.1 M PB containing 4% paraformaldehyde and 3% sucrose and 
processed for immunohistochemistry as described previously. A standard 
immunohistochemical procedure was then performed as described in detail previously43 
utilizing the following antibodies on separate serial sections: affinity purified rabbit anti-
ADAM22 polyclonal antibody (1:200 dilution; cat. no. ab56122, Abcam, Cambridge, MA); 
rabbit anti-CAP1 polyclonal antibody (1:200 dilution, cat. no. sc134637, Santa Cruz 
Biotechnology, Santa Cruz CA); affinity purified rabbit anti-HSP70 affinity purified 
polyclonal antibody (1:100 dilution, cat. no. NBP1-00880, Novus Biologicals, Littleton Co). 
Abcam reports the following: The ADAM22 immunogen was a synthetic peptide based on 
the metalloproteinase domain of human ADAM22, and the ADAM22 antibody is reactive 
with mouse ADAM22 protein at the predicted band in Western Blots. Santa Cruz reports 
that the CAP1 rabbit polyclonal antibody was raised against amino acids 14–74 mapping 
near the N-terminus of CAP1 of human origin and is reactive with mouse CAP1 protein at 
the predicted band in Western Blots. Novus Biologicals reports that the CAP1 antibody was 
raised against the synthetic peptide corresponding to the residues surrounding Phenylalanine 
245 of human HSP70, and reactive with mouse HSP70 protein at the predicted band in 
Western Blots.
Photography and cell counts
Photomicrographs were obtained using a Leica brightfield microscope using N plan 5x, 10x, 
20x and 40x objective lenses (model DMLB, Leica Microsystems), a SPOT digital camera 
(RT color, Diagnostics Instruments Inc., Sterling Heights, MI) and SPOT 4.7.1.32 for 
Windows digital imaging software. Photographic plates were prepared in CorelDraw X5 for 
Windows (Eden Prairie, MN). Immunoreactive (ir) cells in the BLA were counted on a 400 
x magnification photomicrograph and then verified at 400X using a Leica DMLB binocular 
microscope (Leica Microsystems) by an investigator (PLJ), who was blind to the 
experimental treatment of each animal.
Site Directed Injections of a Pak1 Inhibitor into the BLA of NF1 mice
Stereotaxic Cannula Placement—Prior to and during surgery, mice were anesthetized 
with a nose cone connected to an isoflurane system (MGX Research Machine; Vetamic) and 
placed in an ultraprecise stereotaxic apparatus for rodents (900 series Ultraprecise Kopf 
Instruments). Bilateral injection cannulae (26 gauge; Plastics One) were implanted into the 
BLA (AP: −1.5; ML: +/− 3.35; DV: −4.55; and incisor bar was set at −3.0 mm to keep 
lambda and bregma suture at same DV) according to a standard stereotaxic atlas of the 
mouse brain48. The cannulas were secured to the skull with three stainless steel screws (2.8 
mm, Plastic One, Roanoke VA) and Loctite adhesive. Upon completion of surgery a dummy 
cannula that went the length of the guide were screwed in place. All mice then received 
buprenex 1 mg/kg s.c. and were placed on a warming pad until fully recovered.
Intracranial Injection Procedures—At 30 min prior to the novel mouse exposure and 
the long term social memory testing the next day, WT and Nf1+/− mice received 
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microinjections via an injector (33 gauge, Plastic Products) that fit into, and extended 0.5 
mm beyond, the guide cannula. A 10 μl Hamilton syringe was placed on an infusion pump 
(Harvard Apparatus, Holliston, MA, model PHD 2000) and connected to the injection 
cannula via polyethylene (PE 50) tubing. The pump delivered 100 nl of either the Pak1 
inhibitor IPA3 (cat. no. 3622, Tocris Biosciences, n=6) or the inactive enantiomer PIR3.5 
(cat no. 4212, Tocris Biosciences, n=6) dissolved in DMSO into the BLA per site over 30 
seconds. The injection cannula remained in place for an additional minute to ensure 
complete delivery of the solution and proper flow was confirmed in the cannulae after 
removal. All injection sites were verified using 400X magnification Leica DMLB brightfield 
microscope.
Statistical Analyses of Data
For behavior tests in figure 1 with western blotting and immunohistochemistry with WT and 
Nf1+/− mice data were analyzed using one-way or analyses of variance (ANOVAs) with 
genotype as the main factor and when applicable a side preference or time as a repeated 
measure. For behavior tests in figure 2 with Nf1+/−, Nf1+/−/Pak1−/− and Pak1−/− mice, data 
were analyzed using one-way or analyses of variance (ANOVAs) with genotype as the main 
factor and when applicable a side preference or time as a repeated measure. For 
electrophysiology in figure 3, and proteomics and immunohistochemistry in Table 1 and 
Figure 4 and behavior tests in figure 5 with WT, Nf1+/−, Nf1+/−/Pak1−/− and Pak1−/− mice, 
data were analyzed using a two-way analyses of variance (ANOVAs) with Nf1+/− and 
Pak1−/− as the main factors or genotype and drug treatment as main factors and when 
applicable a side preference or time as a repeated measure. Significant effects were further 
analyzed using post hoc Fisher’s protected least significant difference (FLSD) tests for 
between subjects effects of multiple groups, or a 2 way paired or independent t-test (as 
appropriate) for 2 group comparisons. A Dunnett’s post-hoc test was used to compare within 
subject over time effects in Fig. 3. A Levene’s Test was conducted prior to analyses to 
assess for equality of variance. To protect against type I errors, the n’s per group were 
considered acceptable if significant (P < 0.05) in the previously mentioned analyses. In cases 
where there was a trend towards significance (P > 0.05 –0.060), power analyses were done 
to determine if the n’s per group were sufficiently powered, and to protect against type II 
errors. An outlier was detected for one animal in the behavioral assessments in Figure. 1c 
and also in Figure 5a with a Grubb’s test, and were therefore excluded. There were no 
missing data for cell assays, westerns, proteomics, or electrophysiology. For proteomics 
analyses, using Pathway analyses in INGENUITY software, there were no missing data 
points. However in a subsequent secondary analyses using one-way ANOVAs, there was 
one missing data point in the CAP1 WT group due to an outlier that was >2 standard 
deviations from the mean (Fig. 4a). For immunohistochemistry, one data point was missing 
in the CAP1 WT group (Fig. 4d), and the HSP70 Nf1+/− group (Fig. 4e) due to there being 
no representative coronal slice containing the amygdala at that level of bregma, and another 
data point in the CAP1 WT group that was an outlier.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Nf1+/− mice show selective deficits in long-term social learning and increased MAPK 
activation in the amygdala compared to wild-type (WT) mice
Figure 1a–c depicts the time spent sniffing wire cages containing “stimulus” mice in a three-
chambered apparatus (refer to insets that illustrate the orientation of cages and when cages 
were empty or contained a novel or familiar mouse). No differences were detected between 
strains in (a) preference for social interaction or (b) short-term social learning (1–3 min. 
following exposure to “test” mouse). c–d) Unlike WT, Nf1+/− mice show deficits in long-
term social learning, as measured by preference for social novelty (24 hrs. following 
exposure to “test” mouse). (d) represents comprehensive heat maps of time spent in each 
region. No differences were observed in learning in the (e) novel object recognition test or 
(f) passive avoidance test; anxiety states in the (g–h) elevated plus maze; depression/despair 
in the (i) forced swim test; or olfaction in an (j) olfactory habituation. (k) The Nf1+/− 
genotype is associated with MAPK hyperexcitation in neuronal cultures from the prefrontal 
cortex (PFC, left graph. Western blotting was used to quantify pERK1/2 in cultured cortical 
neurons at basal levels and 2 min following stimulation with SCF (10 ng/ml), and total 
Erk1/2 was used as loading controls. Compared to WT mice, MAPK hyperexcitation was not 
apparent in the basolateral amydala (BLA) region of Nf1+/− mice in (k, right graph and 
cropped western blots; full-length blots/gels are presented in Suppl. Fig. 3), but it (l) was 
apparent in cells immunoreactive for pERK within the BLA, but not medial amygdala 
(MEA) of Nf1+/− mice exposed to a novel mouse. Graphs depict mean ± SEM for WT 
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(white) and Nf1+/− (red) mice. *P < 0.05. High magnification photographs (I, right) show 
pERK immunoreactive cells in lateral BLA (lBLA) and medial BLA/amygdaloid 
intermedullary grey (mBLA/IMG) of WT and Nf1+/− mice.
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Figure 2. Deficits in long-term social learning in Nf1+/− mice are rescued in Nf1+/−/Pak1−/− mice
Figure 2a–d depicts the time spent sniffing wire cages containing “stimulus” mice in a three-
chambered apparatus (refer to insets that illustrate the orientation of cages and when cages 
were empty or contained a novel or familiar mouse; Nf1+/−; Nf1+/−/Pak1−/−; Pak1−/−). 
Similar to our previous findings, no differences were detected between strains in (a) 
preference for social interaction or (b) short-term social learning. (c) Unlike Nf1+/− mice, 
Nf1+/−/Pak1−/− showed significant preference for social novelty or restored long-term 
social learning (24 hrs. following exposure to “test” mouse). (d) represents comprehensive 
heat maps of time spent in each region. No differences were observed in (e) anxiety as 
measured by elevated plus maze, (f) depression-associated behavior, or (g) olfactory 
habituation. Graphs depict mean ± SEM for Nf1+/− (red), Nf1+/−/Pak1−/− (purple), and 
Pak1−/− (blue) mice. *P < 0.05.
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Figure 3. Nf1+/− mice exhibit elevated GABA and glutamate tones and significant LTP deficits in 
the BLA. Co-deletion of the Pak1 gene restores GABA neurotransmission and LTP in the BLA
(a) Representative electrophysiological recordings of sIPSC at holding potential of −55 mV 
from pyramidal neurons of the BLA of WT, Nf1+/−, Nf1+/−/Pak1+/+ and Pak1+/+ mice. 
(b,c) Neurons from Nf1+/− mice exhibit no differences in sIPSC and mIPSC amplitude, but 
have significantly higher sIPSC and mIPSC frequency in the BLA compared to WT (n = 
11,11,14,14). (d) The representative recordings of isolated sEPSC and mEPSC from BLA 
pyramidal neurons at a holding potential of −60 mV in WT, Nf1+/−, Nf1+/−/Pak1−/−, 
Pak1−/− mice. (e,f) Compared to WT, Nf1+/− mice showed significant increases in 
frequency of sEPSCs (n = 17,14,16,19) and mEPSCs (n = 17,15,13,15), but not amplitude of 
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sEPSCs and mEPSCs. Nf1+/−/Pak1−/− and Pak1−/− mice demonstrated significant increase 
of sEPSC and mEPSC amplitude (e) and no significant changes in sEPSC and mEPSC 
frequency (f) compared to WT mice. *represents P ≤ 0.05 compared to control. (g) 
Representative traces of EPSPs before (1) and 60 min after (2) TBS stimulation of thalamic 
inputs to the BLA at holding potential of −70 mV. (h) Time course of averaged evoked 
EPSCs in response to stimulation of thalamic afferents in all neurons recorded from WT 
(white circle), Nf1+/− (red), Nf1+/−/Pak1−/− (purple) and Pak1−/− (blue) mice, respectively. 
TBS-LTP amplitude was significantly lower in Nf1+/−, compared to WT mice. The 
significant depression of LTP was restored by co-deletion of Pak1. Data represent the mean 
± SEM for each group; *represents P < 0.05 for comparison within groups. #(black) 
represents P < 0.05 Nf1+/− vs WT mice, #(purple) - Nf1+/− vs Nf1+/−/Pak1−/− mice. (i) The 
summary graph showing the group data for the effects of tetanic stimulation protocol on 
EPSP amplitude before (Control) and 60 min after stimulation in WT (white, n = 7), Nf1+/− 
(red, n = 12), Nf1+/−/Pak1−/− (purple, n = 8), and Pak1−/− (blue, n = 5) mice. Graphs depict 
mean ± SEM for each group. *represents P < 0.05 compared to control..
Molosh et al. Page 22
Nat Neurosci. Author manuscript; available in PMC 2015 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 4. Reductions in ADAM22 levels and number of immunopositive cells seen in the BLA of 
Nf1+/− mice were rescued by the co-deletion of Pak1 gene
Graphs in (a–b) represents normalized protein expression of ADAM22, CAP1 and HSP70 in 
the BLA of WT, Nf1+/−, Nf1+/−/Pak1−/−, and Pak1−/− mice. Graphs in (d–f) respectively 
represents the number of ADAM22, CAP1 and HSP70 immunoreactive (ir) cells in the BLA 
of WT and Nf1+/− mice (and additional Nf1+/−/Pak1−/−, and Pak1−/− mice for only 
ADAM22). Bars represent the mean and error bars represent the standard error of the mean. 
* and # in a–c respectively indicate P < 0.05. (f) contains low (left) and high (right) 
photomicrographs of ADAM22-immunoreactive cells in the amygdala of WT, Nf1+/−, 
Nf1+/−/Pak1−/−, and Pak1−/− mice. CeA and BLA are indicated with arrows in left row. 
Dashed lined box in left photomicrographs indicated where cells were counted and also 
where high magnification photomicrographs to right are taken. Scale bar for 
photomicrographs in left and right rows and inset are respectively, 25, 75 and 375 μm. See 
Suppl. Fig. 1b for a hypothetical illustration depicting glutamate and GABA regulation of 
normal EPSCs, LTP and IPSCs activity in WT mice, and how in Nf1+/− mice disruption of 
ADAM22 interrupts anchoring of AMPA receptors to the post-synaptic membrane and leads 
to non-sustainable LTP as demonstrated in Figure 3h. Similarly, increased expression of 
HSP70 could contribute to increases in pre-synaptic GABA release and increased frequency 
of IPSCs seen in Figure 3c. Abbreviations: BLA, basolateral amygdala; CeA, central 
amygdala.
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Figure 5. Bilateral injections of a PAK1 inhibitor IPA3 (and not the inactive enantiomer PIR3.5) 
into the BLA of Nf1+/− mice rescues their social learning deficits
(a) depicts the time spent in close proximity to either the novel or familiar mouse cage (≤ 
2.5cm from wire cage) [* indicates a novel mouse preference, # indicates an enhanced social 
preference in WT mice, and a rescue of social preference in Nf1+/− mice, P < 0.05]. Graphs 
depict mean ± SEM. (b) is an illustration of a coronal mouse brain section (taken from 
Paxinos & Franklin stereotaxic atlas of the mouse brain, 3rd edition38) indicating the 
location of the injection sites (indicated by red circles) within the BLA from −1.46 to −1.94 
mm bregma with a 0.5 mm scale bar at bottom right. Abbreviations: CeA, central amygdala; 
ec, external capsule; LA, lateral amygdala; opt, optic tract. (c) representative heat maps of 
time spent in each region with IPA3 groups spending more time near novel mouse cage. (d) 
Bar graph represents the number of ADAM22-immunoreactive (ir) cells in the BLA of WT 
and Nf1+/− mice treated with vehicle or IPA3 from crossover experiment from Fig. 5a–c. 
Bars represent the mean and error bars represent the standard error of the mean. *indicates a 
P < 0.05 versus all other groups. (e) contains photomicrographs of ADAM22-
immunoreactive cells in the BLA of WT, Nf1+/− mice treated with vehicle or IPA3. Scale 
bar for photomicrograph is 25 μm.
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Table 1
Protein expression differences (from 380 proteins screened) in the basolateral amygdala 
of Nf1+/− mice that were rescued by the co-deletion of Pak1 gene (see also Fig. 4a–c for 
bar graphs)
Of the 380 proteins that were assessed in the BLA, there were an additional 70 that had significant differences 
in expression in Nf1+/− deficient mice compared to WT controls, but were not rescued (see Suppl. Table 1). 
Columns represent proteins showing full or partial rescue with Pak1−/− co-deletion with Nf1+/−. Column 2 is 
the locus ID of each protein. Column 3 represents fold changes in protein expression in Nf1+/− mice compared 
to WT controls. Column 5 represents definitions for abbreviated proteins in column 1.
Protein Locus ID Fold-change Description
‡
 CAP1 P40124 3.05 Adenylate cyclase-associated protein 1
‡
 HSP70 P63017 1.71 Heat shock protein 70
*
 
†
 ADAM22 Q9R1V6 −6.17 ADAM metallopeptidase domain 22
‡, † and *
symbols respectively indicated P < 0.05 using: ProteinQant; one-way ANOVA; or a two-way ANOVA [performed on log transformed 
protein expression data].
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